Seeing Is Believing
with an average price target of $6.83. This is a potential upside of $6.83 (0%) from yesterday's end of day stock price of $0.
Genomic Health's activity chart (see below) currently has 28 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 74.1% with an average time for these price targets to be met of 228.6 days.
Most recent stock forecast was given by MARK MASSARO from BTIG on 30-Jul-2019. First documented stock forecast 18-Jun-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$72
$8.56 (13.49%)
$77
5 years 8 months 24 days ago
(30-Jul-2019)
4/7 (57.14%)
$-2 (-2.70%)
284
Buy
$72
$8.56 (13.49%)
$72
5 years 10 months 3 days ago
(20-Jun-2019)
4/5 (80%)
$16.88 (30.62%)
99
$55
$-8.44 (-13.30%)
$31
5 years 10 months 24 days ago
(30-May-2019)
5/5 (100%)
$2 (3.77%)
678
$69
$5.56 (8.76%)
$97
5 years 11 months 14 days ago
(09-May-2019)
1/3 (33.33%)
$17.39 (26.13%)
81
Hold
$50
$-13.44 (-21.19%)
6 years 10 months 10 days ago
(13-Jun-2018)
1/1 (100%)
$-0.1 (-0.20%)
1
What is GHDX (Genomic Health) average time for price targets to be met?
Which analyst has the current highest performing score on GHDX (Genomic Health) with a proven track record?
Which analyst has the current lower performing score on GHDX (Genomic Health) with a proven track record?
Which analyst has the most public recommendations on GHDX (Genomic Health)?
Which analyst is the currently most bullish on GHDX (Genomic Health)?
Which analyst is the currently most reserved on GHDX (Genomic Health)?